Financial Ratios

REMEDIUM LIFECARE LTD.

NSE : NABSE : 539561ISIN CODE : INE549S01036Industry : TradingHouse : Private
BSE108.50-1.65 (-1.5 %)
PREV CLOSE ( ) 110.15
OPEN PRICE ( ) 110.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 469831
TODAY'S LOW / HIGH ( )104.65 114.80
52 WK LOW / HIGH ( ) 23.96179.66
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)15.072.991.330.770.02
   CEPS(Rs)0.550.110.050.030.01
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)28.7913.7210.729.328.55
   Tax Rate(%)26.6329.3326.4126.1358.33
Margin Ratios
   Core EBITDA Margin(%)1.410.360.8013.42-43.18
   EBIT Margin(%)1.540.350.7413.2712.13
   Pre Tax Margin(%)1.450.300.7312.9712.07
   PAT Margin (%)1.060.210.539.585.03
   Cash Profit Margin (%)1.090.230.6010.045.03
Performance Ratios
   ROA(%)0.790.822.257.110.24
   ROE(%)70.9224.5113.338.620.26
   ROCE(%)102.5418.167.3911.160.62
   Asset Turnover(x)0.743.854.210.740.05
   Sales/Fixed Asset(x)1909.861621.56339.3011.83
   Working Capital/Sales(x)49.60106.236.360.830.05
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.000.000.080.00
   Receivable days84.6131.7051.05103.362487.09
   Inventory Days32.6431.457.7257.20469.61
   Payable days77.1554.3150.2580.601426.41
Valuation Parameters
   PER(x)48.9446.2632.9728.98695.95
   PCE(x)47.6143.3029.3027.67695.25
   Price/Book(x)25.6210.104.112.391.81
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.480.100.282.5828.66
   EV/Core EBITDA(x)30.4726.5235.0518.83236.23
   EV/EBIT(x)31.0627.6438.2019.48236.23
   EV/CE(x)0.210.220.661.751.29
   M Cap / Sales0.520.100.182.7834.96
Growth Ratio
   Net Sales Growth(%)1.00460.673015.141716.59-54.57
   Core EBITDA Growth(%)337.97150.6183.731954.405.46
   EBIT Growth(%)347.82162.1074.331886.5314.20
   PAT Growth(%)403.44124.3173.473362.50-41.18
   EPS Growth(%)403.44124.3173.473365.97-41.24
Financial Stability Ratios
   Total Debt/Equity(x)0.000.002.720.110.02
   Current Ratio(x)1.011.021.597.389.44
   Quick Ratio(x)1.000.641.466.108.89
   Interest Cover(x)17.467.7243.1245.64193.00
   Total Debt/Mcap(x)0.000.000.660.050.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.